Lisa E. Porter
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 2
- Diabetes Management and Research 2
-
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Ken Wilhelm (2 shared papers)Brandon Walsh (2 shared papers)Martin I. Freed (5 shared papers)Richard M. Bergenstal (1 shared paper)Leigh MacConell (1 shared paper)Ping Yan (1 shared paper)Jaret L. Malloy (1 shared paper)Carol Wysham (1 shared paper)
- Journals
- Diabetologia (1 paper)Journal of Hypertension (1 paper)Journal of Human Hypertension (1 paper)Hypertension (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Lisa E. Porter
11 papers receiving 1.5k citations
Lisa E. Porter's Hit Papers
Peers
Comparison fields: 5 of 67
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 149
- Pharmacology 202
- Cardiology and Cardiovascular Medicine 241
- Surgery 263
Countries citing papers authored by Lisa E. Porter
This map shows the geographic impact of Lisa E. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa E. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa E. Porter more than expected).
Fields of papers citing papers by Lisa E. Porter
This network shows the impact of papers produced by Lisa E. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa E. Porter. The network helps show where Lisa E. Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Lisa E. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial Hit paper breakdown → | 2010 | 528 |
| 2 | 2010 | 301 | |
| 3 | 1999 | 236 | |
| 4 | 2003 | 205 | |
| 5 | 2006 | 90 | |
| 6 | 2015 | 87 | |
| 7 | 2005 | 54 | |
| 8 | 1998 | 51 | |
| 9 | 2004 | 46 | |
| 10 | 1997 | 1 | |
| 11 | Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study | 2003 | 1 |
About Lisa E. Porter
Lisa E. Porter is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Nutrition and Dietetics and Molecular Biology, having authored 11 papers that have together received 1.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Diabetes Management and Research (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Renal function and acid-base balance (1 paper) and Sodium Intake and Health (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (149 citations), Pharmacology (202 citations), Cardiology and Cardiovascular Medicine (241 citations) and Surgery (263 citations). Lisa E. Porter has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Ken Wilhelm, Brandon Walsh, Martin I. Freed, Richard M. Bergenstal, Leigh MacConell, Ping Yan, Jaret L. Malloy, Carol Wysham, Mark A. Heise and Norman K. Hollenberg. Their work appears in journals such as Diabetologia, Journal of Hypertension, Journal of Human Hypertension, Hypertension and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.